These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1934454)

  • 61. [Eosinophilia-myalgia syndrome and L-tryptophan intake].
    von Gizycki-Nienhaus B; Meurer M; Krieg T; Braun-Falco O
    Hautarzt; 1991 Mar; 42(3):179-82. PubMed ID: 1829070
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Upper extremity contractures in a patient with eosinophilia-myalgia syndrome.
    Marchman HB; Gleason CB; Shaw JC
    Arch Phys Med Rehabil; 1991 Nov; 72(12):1029-30. PubMed ID: 1953317
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [L-tryptophan-associated chronic eosinophilia-myalgia syndrome treated with cyclosporin].
    Schubert S; Trautmann F; Dreher R
    Z Rheumatol; 1992; 51(4):158-62. PubMed ID: 1414039
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Acute respiratory failure as a manifestation of eosinophilia-myalgia syndrome associated with L-tryptophan intake].
    Grangeia Tde A; Schweller M; Paschoal IA; Zambon L; Pereira MC
    J Bras Pneumol; 2007; 33(6):747-51. PubMed ID: 18200378
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cutaneous manifestations of the eosinophilia-myalgia syndrome.
    Oursler JR; Farmer ER; Roubenoff R; Mogavero HS; Watson RM
    Br J Dermatol; 1992 Aug; 127(2):138-46. PubMed ID: 1390142
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Eosinophilia-myalgia syndrome].
    Reinauer S; Plewig G
    Hautarzt; 1991 Mar; 42(3):137-9. PubMed ID: 2055761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Eosinophilic rheumatic disorders.
    Clauw DJ; Crofford LJ
    Rheum Dis Clin North Am; 1995 Feb; 21(1):231-46. PubMed ID: 7732171
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.
    Cilursu AM; Goeken J; Olson RR
    Ann Rheum Dis; 1991 Nov; 50(11):817-9. PubMed ID: 1772299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Eosinophilia-myalgia syndrome in Wisconsin.
    Butler JC; Davis JP
    Wis Med J; 1990 Dec; 89(12):687-91. PubMed ID: 2293489
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Peripheral neuropathy in the eosinophilia-myalgia syndrome associated with L-tryptophan ingestion.
    Smith BE; Dyck PJ
    Neurology; 1990 Jul; 40(7):1035-40. PubMed ID: 2162498
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Demyelinating polyneuropathy in eosinophilia-myalgia syndrome.
    Donofrio PD; Stanton C; Miller VS; Oestreich L; Lefkowitz DS; Walker FO; Ely EW
    Muscle Nerve; 1992 Jul; 15(7):796-805. PubMed ID: 1323757
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The Eosinophilia-Myalgia Studies of Oregon, New York and New Mexico.
    Philen RM; Hill RH; Flanders WD; Caudill SP; Needham L; Sewell L; Sampson EJ; Falk H; Kilbourne EM
    Am J Epidemiol; 1993 Aug; 138(3):154-9. PubMed ID: 8356958
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Eosinophilia-myalgia syndrome associated with L-tryptophan use.
    Glickstein SL; Gertner E; Smith SA; Roelofs RI; Hathaway DE; Schlesinger PA; Schned ES
    J Rheumatol; 1990 Nov; 17(11):1534-43. PubMed ID: 2273499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The tryptophan-associated eosinophilia-myalgia syndrome. A clinical follow-up of 8 patients].
    Szeimies RM; Meurer M
    Dtsch Med Wochenschr; 1993 Feb; 118(7):213-20. PubMed ID: 8440161
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.
    Silver RM; Heyes MP; Maize JC; Quearry B; Vionnet-Fuasset M; Sternberg EM
    N Engl J Med; 1990 Mar; 322(13):874-81. PubMed ID: 1690352
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Histopathologic features of the L-tryptophan-related eosinophilia-myalgia (fasciitis) syndrome.
    Winkelmann RK; Connolly SM; Quimby SR; Griffing WL; Lie JT
    Mayo Clin Proc; 1991 May; 66(5):457-63. PubMed ID: 1709432
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Eosinophilia-myalgia syndrome after L-tryptophan intake].
    Zillikens D; Bammel A; Lurz C; Elsner P; Burg G
    Hautarzt; 1991 Mar; 42(3):154-7. PubMed ID: 2055764
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.
    Hertzman PA; Blevins WL; Mayer J; Greenfield B; Ting M; Gleich GJ
    N Engl J Med; 1990 Mar; 322(13):869-73. PubMed ID: 2314421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The eosinophilia-myalgia syndrome and eosinophilic fasciitis.
    Jimenez SA; Varga J
    Curr Opin Rheumatol; 1991 Dec; 3(6):986-94. PubMed ID: 1772754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.